Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1993 Oct;61(10):4302–4309. doi: 10.1128/iai.61.10.4302-4309.1993

Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells.

A H Limper 1, J E Standing 1, O A Hoffman 1, M Castro 1, L W Neese 1
PMCID: PMC281158  PMID: 7691747

Abstract

Pneumocystis carinii attaches to alveolar epithelial cells during the development of pneumonia. Adhesive proteins found within the alveolar space have been proposed to mediate P. carinii adherence to lung cells. Vitronectin (Vn), a 75-kDa glycoprotein present in the lower respiratory tract, has substantial cell-adhesive properties and might participate in the host-parasite interaction during P. carinii pneumonia. To address whether Vn binds to P. carinii, we studied the interaction of radiolabeled Vn with purified P. carinii organisms. Vn bound to P. carinii, occupying an estimated 5.47 x 10(5) binding sites per organism, with an affinity constant, Kd, of 4.24 x 10(-7) M. Interestingly, the interaction of Vn with P. carinii was not mediated through the Arg-Gly-Asp cell-adhesive domain of Vn. Addition of Arg-Gly-Asp-Ser (RGDS) peptides did not inhibit binding. In contrast, Vn binding to P. carinii was substantially inhibited by the addition of heparin or by digesting the organisms with heparitinase, suggesting that P. carinii may interact with the glycosaminoglycan-binding domain of Vn. To determine whether Vn might enhance P. carinii attachment to lung epithelial cells, we studied the binding of 51Cr-labeled P. carinii to cultured A549 lung cells. Addition of Vn resulted in significantly increased binding of P. carinii to A549 cells, whereas a neutralizing anti-Vn serum substantially reduced the binding of P. carinii to A549 cells. These data suggest that Vn binds to P. carinii and that Vn might provide an additional means by which P. carinii attaches to respiratory epithelial cells.

Full text

PDF
4302

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M. Endothelial and epithelial cell adhesion molecules. Am J Respir Cell Mol Biol. 1991 Mar;4(3):195–203. doi: 10.1165/ajrcmb/4.3.195. [DOI] [PubMed] [Google Scholar]
  2. Bartlett M. S., Fishman J. A., Queener S. F., Durkin M. M., Jay M. A., Smith J. W. New rat model of Pneumocystis carinii infection. J Clin Microbiol. 1988 Jun;26(6):1100–1102. doi: 10.1128/jcm.26.6.1100-1102.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartlett M. S., Verbanac P. A., Smith J. W. Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol. 1979 Dec;10(6):796–799. doi: 10.1128/jcm.10.6.796-799.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bauer N. L., Paulsrud J. R., Bartlett M. S., Smith J. W., Wilde C. E., 3rd Pneumocystis carinii organisms obtained from rats, ferrets, and mice are antigenically different. Infect Immun. 1993 Apr;61(4):1315–1319. doi: 10.1128/iai.61.4.1315-1319.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blumenfeld W., Mandrell R. E., Jarvis G. A., Griffiss J. M. Localization of host immunoglobulin G to the surface of Pneumocystis carinii. Infect Immun. 1990 Feb;58(2):456–463. doi: 10.1128/iai.58.2.456-463.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell W. G., Jr Ultrastructure of Pneumocystis in human lung. Life cycle in human pneumocystosis. Arch Pathol. 1972 Apr;93(4):312–324. [PubMed] [Google Scholar]
  7. Chhatwal G. S., Preissner K. T., Müller-Berghaus G., Blobel H. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect Immun. 1987 Aug;55(8):1878–1883. doi: 10.1128/iai.55.8.1878-1883.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cushion M. T., Ruffolo J. J., Linke M. J., Walzer P. D. Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines. Exp Parasitol. 1985 Aug;60(1):43–54. doi: 10.1016/s0014-4894(85)80021-7. [DOI] [PubMed] [Google Scholar]
  9. Cushion M. T., Walzer P. D. Growth and serial passage of Pneumocystis carinii in the A549 cell line. Infect Immun. 1984 May;44(2):245–251. doi: 10.1128/iai.44.2.245-251.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fishman J. A., Samia J. A., Fuglestad J., Rose R. M. The effects of extracellular matrix (ECM) proteins on the attachment of Pneumocystis carinii to lung cell lines in vitro. J Protozool. 1991 Nov-Dec;38(6):34S–37S. [PubMed] [Google Scholar]
  11. Gigliotti F., Stokes D. C., Cheatham A. B., Davis D. S., Hughes W. T. Development of murine monoclonal antibodies to Pneumocystis carinii. J Infect Dis. 1986 Aug;154(2):315–322. doi: 10.1093/infdis/154.2.315. [DOI] [PubMed] [Google Scholar]
  12. Graves D. C., McNabb S. J., Ivey M. H., Worley M. A. Development and characterization of monoclonal antibodies to Pneumocystis carinii. Infect Immun. 1986 Jan;51(1):125–133. doi: 10.1128/iai.51.1.125-133.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hayman E. G., Pierschbacher M. D., Suzuki S., Ruoslahti E. Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res. 1985 Oct;160(2):245–258. doi: 10.1016/0014-4827(85)90173-9. [DOI] [PubMed] [Google Scholar]
  14. Hetland G., Pettersen H. B., Mollnes T. E., Johnson E. S-protein is synthesized by human monocytes and macrophages in vitro. Scand J Immunol. 1989 Jan;29(1):15–21. doi: 10.1111/j.1365-3083.1989.tb01094.x. [DOI] [PubMed] [Google Scholar]
  15. Itatani C. A., Marshall G. J. Ultrastructural morphology and staining characteristics of Pneumocystis carinii in situ and from bronchoalveolar lavage. J Parasitol. 1988 Aug;74(4):700–712. [PubMed] [Google Scholar]
  16. Lee C. H., Lu J. J., Bartlett M. S., Durkin M. M., Liu T. H., Wang J., Jiang B., Smith J. W. Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol. 1993 Mar;31(3):754–757. doi: 10.1128/jcm.31.3.754-757.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Limper A. H., Martin W. J., 2nd Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest. 1990 Feb;85(2):391–396. doi: 10.1172/JCI114451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Limper A. H., Offord K. P., Smith T. F., Martin W. J., 2nd Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989 Nov;140(5):1204–1209. doi: 10.1164/ajrccm/140.5.1204. [DOI] [PubMed] [Google Scholar]
  19. Limper A. H. Parasitic adherence and host responses in the development of Pneumocystis carinii pneumonia. Semin Respir Infect. 1991 Mar;6(1):19–26. [PubMed] [Google Scholar]
  20. Limper A. H., Pottratz S. T., Martin W. J., 2nd Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J Lab Clin Med. 1991 Nov;118(5):492–499. [PubMed] [Google Scholar]
  21. Long E. G., Smith J. S., Meier J. L. Attachment of Pneumocystis carinii to rat pneumocytes. Lab Invest. 1986 Jun;54(6):609–615. [PubMed] [Google Scholar]
  22. McDonald J. A. Receptors for extracellular matrix components. Am J Physiol. 1989 Dec;257(6 Pt 1):L331–L337. doi: 10.1152/ajplung.1989.257.6.L331. [DOI] [PubMed] [Google Scholar]
  23. Murray J. F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis. 1990 Jun;141(6):1582–1598. doi: 10.1164/ajrccm/141.6.1582. [DOI] [PubMed] [Google Scholar]
  24. Parker C. J., Frame R. N., Elstad M. R. Vitronectin (S protein) augments the functional activity of monocyte receptors for IgG and complement C3b. Blood. 1988 Jan;71(1):86–93. [PubMed] [Google Scholar]
  25. Pohl W. R., Conlan M. G., Thompson A. B., Ertl R. F., Romberger D. J., Mosher D. F., Rennard S. I. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis. 1991 Jun;143(6):1369–1375. doi: 10.1164/ajrccm/143.6.1369. [DOI] [PubMed] [Google Scholar]
  26. Pottratz S. T., Martin W. J., 2nd Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest. 1990 Feb;85(2):351–356. doi: 10.1172/JCI114445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pottratz S. T., Paulsrud J., Smith J. S., Martin W. J., 2nd Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest. 1991 Aug;88(2):403–407. doi: 10.1172/JCI115318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Preissner K. T., Wassmuth R., Müller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J. 1985 Oct 15;231(2):349–355. doi: 10.1042/bj2310349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ruoslahti E., Suzuki S., Hayman E. G., Ill C. R., Pierschbacher M. D. Purification and characterization of vitronectin. Methods Enzymol. 1987;144:430–437. doi: 10.1016/0076-6879(87)44192-x. [DOI] [PubMed] [Google Scholar]
  30. Sepkowitz K. A., Brown A. E., Telzak E. E., Gottlieb S., Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA. 1992 Feb 12;267(6):832–837. [PubMed] [Google Scholar]
  31. Sethi K. K. Multiplication of human-derived Pneumocystis carinii in severe combined immunodeficient (SCID) mice. Experientia. 1992 Jan 15;48(1):63–66. doi: 10.1007/BF01923610. [DOI] [PubMed] [Google Scholar]
  32. Sorice M., Lenti L., Misasi R., Contini C., Cignarella L., Griggi T., Vullo V., Masala C. Evidence for the existence of ganglioside molecules on Pneumocystis carinii from human lungs. Parasitology. 1992 Aug;105(Pt 1):1–6. doi: 10.1017/s0031182000073613. [DOI] [PubMed] [Google Scholar]
  33. Suzuki S., Oldberg A., Hayman E. G., Pierschbacher M. D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985 Oct;4(10):2519–2524. doi: 10.1002/j.1460-2075.1985.tb03965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Suzuki S., Pierschbacher M. D., Hayman E. G., Nguyen K., Ohgren Y., Ruoslahti E. Domain structure of vitronectin. Alignment of active sites. J Biol Chem. 1984 Dec 25;259(24):15307–15314. [PubMed] [Google Scholar]
  35. Walzer P. D., Linke M. J. A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting. J Immunol. 1987 Apr 1;138(7):2257–2265. [PubMed] [Google Scholar]
  36. Yatohgo T., Izumi M., Kashiwagi H., Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct. 1988 Aug;13(4):281–292. doi: 10.1247/csf.13.281. [DOI] [PubMed] [Google Scholar]
  37. Zimmerman P. E., Voelker D. R., McCormack F. X., Paulsrud J. R., Martin W. J., 2nd 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest. 1992 Jan;89(1):143–149. doi: 10.1172/JCI115554. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES